Stock Screener App

無料 -

インストール

2.66

1.85% -0.05

Sl Science Holding Ltd (SLBT)

概要ニュース株価時系列ディスカッション予測

Sl Science Holding Ltd (SLBT) 最新ニュース

Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance

AbCellera Stock Soars 30% After Menopause Drug ABCL635 Hits Phase 2 Success In Hot Flash Trial Results - International Business Times Australia

Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK

SL Science Holding Ord Shs (SLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

SL Science Holding Ord Shs (SLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

SLBT|SL Science Holding Ord Shs|Price:2.820|Chg%:-0.300 - TradingKey

SL Science Holding Ord Shs (SLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

SL Science Holding Ord Shs (SLBT) Cash Flow - TradingKey

SL Science Holding Ord Shs (SLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey

SL Science Holding Ord Shs (SLBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

SL Science Holding Ord Shs (SLBT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com

Kwo Liang Chen Net Worth (2026) - GuruFocus

SLBT|SL Science Holding Ord Shs|Price:3.120|Chg%:-0.050 - TradingKey

SLBT|SL Science Holding Ord Shs|Price:2.620|Chg%:-0.500 - TradingKey

Ching Dong Wang Net Worth (2026) - GuruFocus

Mingche Liu Net Worth (2026) - GuruFocus

The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena -- Who Is Leading? - Yahoo Finance

Lok Sang Leung Net Worth (2026) - GuruFocus

SL Science presents glioblastoma treatment data at WCP 2026 - Investing.com UK

SL Science presents glioblastoma treatment data at WCP 2026 By Investing.com - Investing.com South Africa

Trevi Therapeutics Shares Surge 13% as Biopharma Investors Cheer Cough Drug Data at London Conference - International Business Times Australia

SL Science Holding Limited Exhibits Breakthrough Gamma Delta T Cell Therapy for Glioblastoma at 2026 World Congress of Basic and Clinical Pharmacology - marketscreener.com

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology - The Manila Times

SL Science Showcases Preclinical Gamma Delta T Cell Study Demonstrating Glioblastoma Elimination at WCP 2026 - Quiver Quantitative

Preclinical γδ T cells eradicated a brain tumor by day 26 at highest dose - Stock Titan

4DMedical Shares Plunge 15.57% to $3.20 as Volatile ASX Healthcare Stock's Wild Ride Continues This Week - International Business Times Australia

Ericsson, Q32 Bio and other big stocks moving lower in Tuesday’s pre-market session - MSN

Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm

SL Science seeks US orphan drug designation for γδ T-cell therapy - BioWorld News

Net current asset value per share of SL Science Holding Limited – BOATS:SLBT - TradingView

Number of employees of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Gross margin % of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Price to book ratio of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Net margin % of SL Science Holding Limited – NASDAQ:SLBT - TradingView

SL Science Holding Limited (SLBT-Q) Stock Price and News - The Globe and Mail

Enterprise value to revenue forward of SL Science Holding Limited – BOATS:SLBT - TradingView

Net debt of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Cash flow from investing activities of SL Science Holding Limited – BOATS:SLBT - TradingView

Price to earnings forward of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Enterprise value to EBIT forward of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Enterprise value to EBITDA forward of SL Science Holding Limited – NASDAQ:SLBT - TradingView

EBITDA margin % of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Debt to assets ratio of SL Science Holding Limited – BOATS:SLBT - TradingView

EBITDA per share of SL Science Holding Limited – BOATS:SLBT - TradingView

Debt to equity ratio of SL Science Holding Limited – BOATS:SLBT - TradingView

Enterprise value to EBITDA ratio of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Enterprise value to EBITDA forward of SL Science Holding Limited – BOATS:SLBT - TradingView

EBITDA margin % of SL Science Holding Limited – BOATS:SLBT - TradingView

Enterprise value to EBIT forward of SL Science Holding Limited – BOATS:SLBT - TradingView

Price to earnings forward of SL Science Holding Limited – BOATS:SLBT - TradingView

Price to sales forward of SL Science Holding Limited – BOATS:SLBT - TradingView

Price to book forward of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Enterprise value of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Return on equity % of SL Science Holding Limited – BOATS:SLBT - TradingView

Tangible book value per share of SL Science Holding Limited – BOATS:SLBT - TradingView

EBIT per share of SL Science Holding Limited – NASDAQ:SLBT - TradingView

EBIT per share of SL Science Holding Limited – BOATS:SLBT - TradingView

Cash flow from operating activities of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Cash flow from financing activities of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Asset turnover of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Free cash flow of SL Science Holding Limited – BOATS:SLBT - TradingView

Asset turnover of SL Science Holding Limited – BOATS:SLBT - TradingView

Cash per share of SL Science Holding Limited – BOATS:SLBT - TradingView

Total equity of SL Science Holding Limited – BOATS:SLBT - TradingView

EBITDA of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Total liabilities & shareholders' equities of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Total debt of SL Science Holding Limited – NASDAQ:SLBT - TradingView

Long term debt to total equity ratio of SL Science Holding Limited – BOATS:SLBT - TradingView

SL Science Holding Limited Earnings and Revenue – NASDAQ:SLBT - TradingView

MRNA

$63.32

0.52%

RPRX

$58.60

0.07%

ROIV

$36.20

0.22%

INSM

$123.74

2.05%

ALNY

$228.65

0.67%

ONC

$347.48

2.40%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く